State Street Corp.’s Heaviest Share Holdings in the Healthcare Sector

Wall St. Watchdog reveals information regarding State Street Corp.’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 399 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $55.505 billion.

  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, State Street Corp. reported holding 139,922,435 shares with a market value of $9,307,639,906. This comprised 1.57% of the total portfolio. On 09/30/2011, State Street Corp. reported holding 139,355,603 shares with a market value of $8,875,558,164. This comprised 1.72% of the total portfolio. The net change in shares for this position over the two quarters is -566,832. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, State Street Corp. reported holding 305,296,846 shares with a market value of $6,289,115,144. This comprised 1.06% of the total portfolio. On 09/30/2011, State Street Corp. reported holding 311,478,210 shares with a market value of $5,506,934,848. This comprised 1.07% of the total portfolio. The net change in shares for this position over the two quarters is 6,181,364. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, State Street Corp. reported holding 119,825,655 shares with a market value of $4,228,647,475. This comprised 0.71% of the total portfolio. On 09/30/2011, State Street Corp. reported holding 121,080,080 shares with a market value of $3,959,318,708. This comprised 0.77% of the total portfolio. The net change in shares for this position over the two quarters is 1,254,425. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, State Street Corp. reported holding 58,906,947 shares with a market value of $3,099,683,488. This comprised 0.52% of the total portfolio. On 09/30/2011, State Street Corp. reported holding 58,715,892 shares with a market value of $3,002,730,681. This comprised 0.58% of the total portfolio. The net change in shares for this position over the two quarters is -191,055. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, State Street Corp. reported holding 54,919,639 shares with a market value of $3,204,560,852. This comprised 0.54% of the total portfolio. On 09/30/2011, State Street Corp. reported holding 52,821,080 shares with a market value of $2,903,046,508. This comprised 0.56% of the total portfolio. The net change in shares for this position over the two quarters is -2,098,559. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, State Street Corp. reported holding 64,085,649 shares with a market value of $1,855,920,336. This comprised 0.31% of the total portfolio. On 09/30/2011, State Street Corp. reported holding 63,477,789 shares with a market value of $1,991,932,966. This comprised 0.39% of the total portfolio. The net change in shares for this position over the two quarters is -607,860. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, State Street Corp. reported holding 41,242,638 shares with a market value of $2,127,295,344. This comprised 0.36% of the total portfolio. On 09/30/2011, State Street Corp. reported holding 40,932,974 shares with a market value of $1,887,828,717. This comprised 0.37% of the total portfolio. The net change in shares for this position over the two quarters is -309,664. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Medtronic Inc. (NYSE:MDT): On 06/30/2011, State Street Corp. reported holding 54,842,191 shares with a market value of $2,113,069,552. This comprised 0.36% of the total portfolio. On 09/30/2011, State Street Corp. reported holding 53,542,414 shares with a market value of $1,779,749,931. This comprised 0.35% of the total portfolio. The net change in shares for this position over the two quarters is -1,299,777. About Company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, State Street Corp. reported holding 39,168,189 shares with a market value of $1,469,982,085. This comprised 0.25% of the total portfolio. On 09/30/2011, State Street Corp. reported holding 39,471,196 shares with a market value of $1,459,250,164. This comprised 0.28% of the total portfolio. The net change in shares for this position over the two quarters is 303,007. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Baxter International Inc. (NYSE:BAX): On 06/30/2011, State Street Corp. reported holding 24,115,158 shares with a market value of $1,439,433,748. This comprised 0.24% of the total portfolio. On 09/30/2011, State Street Corp. reported holding 23,947,686 shares with a market value of $1,344,423,077. This comprised 0.26% of the total portfolio. The net change in shares for this position over the two quarters is -167,472. About Company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.

(Note: Data regarding State Street Corp.’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet